The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

Novo Nordisk has bounced back from a sour ending to its Hims & Hers partnership, revealing a new deal with WeightWatchers to expand access to its blockbuster weight loss drug Wegovy (semaglutide). The ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

The announcement expands telehealth firms’ portfolio of branded glp-1 drugs to offer at a time when the Food and Drug Administration (FDA) is prohibiting them from selling and making compounded ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing ...

A research team at the USF College of Nursing is creating a new anti-cancer telemedicine program for older adults.

Once someone decides they need an abortion, they will go to great lengths to get one because they know it is the right ...

In 2022, anti-abortion groups sued to challenge a decision by the Food and Drug Administration allowing the drug to be prescribed via telehealth and sent by mail.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to customers. ... However, the US Food and Drug Administration ...